Pyronaridine‐artesunate (PY‐AS) vs artemether‐lumefantrine (AL)
Serious adverse events (42 days) · adults and children with uncomplicated P falciparum malaria
Pyronaridine‐artesunate (PY‐AS) showed no clear difference in serious adverse events (42 days) compared with artemether‐lumefantrine (AL) (low certainty).
1 finding from 1 review
- Pyronaridine‐artesunate for treating uncomplicated Plasmodium falciparum malaria 2022 · Cochrane Headline outcomes onlyRR 1.16 [0.3, 4.5]3 studies · 2004 participantsLow